MEDNYSEMiscellaneous Food Preparations & Kindred ProductsFiscal year ends December 31

MEDIFAST INC

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026

$12.03+0.15 (+1.26%)

Close on Oct 19, 2026

Market cap: $133.95M
P/E (TTM): –
Dividend yield: 0.00%

Debt

Borrowings on the balance sheet, Jun 30, 2026

Medifast reports no long-term debt line

Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.

Bond issues

Individual notes and bonds outstanding

Bond-level data is not connected yet

Coupon, maturity and amount of each note will come from the debt footnote in Medifast's annual report. Trading prices and yields need FINRA TRACE data.

Where these numbers come from

Parsed from the XBRL in Medifast's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is MED.

Revenue growth-34.0% · median 10.7%

Gross margin69.2% · median 53.6%

Operating margin-6.2% · median 7.6%

Net margin-8.1% · median 12.1%

Company	Revenue	Growth
MKC	$7.69B	+13.2%
WW	$732.24M	-9.3%
MED	$316.93M	-34.0%
OMDA	$309.76M	+47.6%
JVA	$97.13M	+8.2%
DDC	–	–

Company

Next earnings (est.): Nov 2, 2026, during market hours
Exchange: NYSE
Industry: Miscellaneous Food Preparations & Kindred Products
Fiscal year ends: December 31
Employees: 380
Held by institutions: 73.9%
Auditor: RSM US LLP
SEC CIK: 910329

Advertisement
300 × 250